Zhao H. et al. demonstrated that, whereas metformin therapy decreased the expression of BCL-2 in pancreatic cancer cells, it increased the expression of CASP3 and BAX [25]. The gene discussed is BCL2; the disease is familial pancreatic carcinoma.